Hiroo Katsuya

6PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 27, 2026
Phase II study of mFOLFOX6 in advanced gastric cancer patients with severe peritoneal metastases (WJOG10517G), including an individual patient data comparison with JCOG1108/WJOG7312G.

|Aug 21, 2023
HTLV-1 cell-free DNA in plasma as a potential biomarker in HTLV-1 carriers and adult T-cell leukemia-lymphoma.

Hiroo Katsuya, Hideaki Nakamura, Aya Maeda

|Mar 02, 2023
Current and emerging therapeutic strategies in adult T-cell leukemia-lymphoma.

Hiroo Katsuya

|Nov 03, 2022
Higher neutrophil counts are associated with successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia.

Hiroshi Ureshino, Kazuharu Kamachi, Haruhiko Sano

|Sep 23, 2022
An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma.

Koji Izutsu, Shinichi Makita, Kisato Nosaka

Pageof 1

Frequent Collaborators

1 joint publications

Koji Izutsu

1 joint publications

Shinichi Makita

1 joint publications

Kisato Nosaka

1 joint publications

Makoto Yoshimitsu